{"nct_id":"NCT04893486","title":"CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2021-05-06","start_date_type":"ACTUAL","primary_completion_date":"2023-03-13","primary_completion_date_type":"ACTUAL","completion_date":"2023-03-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PVLA"]}